Malignant Pleural Mesothelioma with Pleural Plaques: A Case Report

Main Article Content

Narongpon Dumavibhat, MD, PhD
Ruchira Ruangchira-urai, MD
Nisa Muangman, MD
Punnarerk Thongcharoen, MD
Sitthiphon Bunman, MSc
Apinut Jaroonpipatkul, MD

Abstract

Diffuse malignant mesothelioma (DMM) is an aggressive tumor of the mesothelium associated with a poor prognosis. Asbestos exposure is the major cause of the disease. Furthermore, pleural plaques are also caused by asbestos exposure. The authors present a case with malignant pleural mesothelioma and pleural plaques.

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Dumavibhat N, Ruangchira-urai R, Muangman N, Thongcharoen P, Bunman S, Jaroonpipatkul A. Malignant Pleural Mesothelioma with Pleural Plaques: A Case Report. BKK Med J [Internet]. 2018Feb.20 [cited 2020Jul.15];14(1):43. Available from: https://he02.tci-thaijo.org/index.php/bkkmedj/article/view/222249
Section
Case Report

References

1. Lynette MS, Marina V. Epidemiology. In: Allen TC, editor. Diffuse Malignant Mesothelioma. Springer New York;2015:3-32.
2. Robinson BM. Malignant pleural mesothelioma: an epidemiological perspective. Ann Cardiothorac Surg. 2012;1(4):491–6.
3. Bianchi C, Bianchi T. Malignant mesothelioma: global incidence and relationship with asbestos.Ind Health. 2007;45:379-87.
4. Driscoll T, Nelson DI, Steenland K, et al. The global burden of disease due to occupational carcinogens. Am J Ind Med. 2005;48(6):419-31.
5. Spirtas R, Heineman EF, Bernstein L, et al. Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med. 1994;51(12):804–11.
6. Craighead JE. Epidemiology of mesothelioma and historical background. In: Tannapfel A, editor.Malignant mesothelioma. Heidelberg: Springer;2011:13-25.
7. World Health Organization. Chrysotile asbestos [Internet]. Geneva: WHO;2014.[cited 2018 Jan 5]. Available from:www. who.int/ipcs/assessment/public.../chrysotile_asbestos_summary. pdf
8. Maxim LD, Niebo R, Utell MJ. Are pleural plaques an appropriate endpoint for risk analyses? InhalToxicol. 2015;27(7):321-34.
9. Hillerdal G, Henderson D. (1997). Asbestos, asbestosis, pleural plaques and lung cancer. Scand J Work Environ Health. 23:93–103.
10. Subhannachart P, Dumavibhat N, Siriruttanapruk S. Asbestosrelated diseases in Thailand and review literature. J Med Assoc Thai. 2012;95(Suppl 8):S71-6
11. Chuaychoo B, Luangdansakun N, Chierakul N, et al. Pathological confirmed diagnosis of asbestosis: the first case report in Thailand. J. Med. Assoc. Thai. 2015;98(3):314-19.